Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
2014 Standout
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
2013 StandoutScience
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
2011
Unfolded protein response in cancer: the Physician's perspective
2011
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
2014 Standout
Targeting cancer stem cell pathways for cancer therapy
2020
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
2017 StandoutNobel
Gastrointestinal Stromal Tumors of the Jejunum and Ileum
2006
Clinical diagnosis and staging of cholangiocarcinoma
2011
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
2006 Standout
Cancer Statistics, 2006
2006 Standout
Cholangiocarcinoma
2008
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
2015
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
2004
The immune contexture in cancer prognosis and treatment
2017 Standout
Cancer stem cells revisited
2017 Standout
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Portal vein thrombosis in the neonate: Risk factors, course, and outcome
2006
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Small-molecule proteostasis regulators for protein conformational diseases
2011
Vascular disorders of the liver # †
2008 Standout
A Review on the Dietary Flavonoid Kaempferol
2011 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Radioimmunotherapy of non-Hodgkin’s lymphoma: a critical appraisal
2005
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
2010 Standout
Common pitfalls in preclinical cancer target validation
2017 StandoutNobel
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Biliary Tract Cancers
1999
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
The Hallmarks of Aging
2013 Standout
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Review of clinical radioimmunotherapy
2006
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
ER stress-induced cell death mechanisms
2013 Standout
Breast cancer metastasis: markers and models
2005 Standout
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
2016
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
2009
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
2004
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Virtopsy, a New Imaging Horizon in Forensic Pathology: Virtual Autopsy by Postmortem Multislice Computed Tomography (MSCT) and Magnetic Resonance Imaging (MRI)—a Feasibility Study
2003 Standout
Nonthrombotic Pulmonary Emboli
2000
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
Combination therapy in combating cancer
2017 Standout
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
HSP90 and its inhibitors (Review)
2010
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
UV Radiation and the Skin
2013 Standout
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
2003
Works of Jerrold B. Teitcher being referenced
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
2015
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
2008
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
2016
Hepatic lobar atrophy: association with ipsilateral portal vein obstruction.
1996
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer
2014
A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
2009
Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC).
2014
Ileal Leiomyosarcoma and Leiomyoma
1987
Metastatic Lobular Carcinoma of the Breast
2000
Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.
2003
Venous Air Embolization as a Complication of Pressure Injection of Contrast Media
1987